Here is an alternative take on the numbers If trials are...

Here is an alternative take on the numbers
If trials are successful, which I think we can be reasonably confident that they will, the number of stores will comfortably be above 20,000. At 50/store/week, that's 52,000,000 sold/year. Assuming we manage some licensing deals on say a $1 licensing per $10 sales, there is some additional revenue. I imagine they are targeting a far higher ratio than that. No tax in year 1. A PE ratio, reflecting global growth opportunities and the sector they are in of X25 is realistic. Admin costs of say $3 mill. Rev from sales plus licensing of US$20 mill = AUD$26 mill. NPAT AUD$23 mill. 175 mill shares on issue so an EPS of 13c . PE X25 gives a shareprice of over $3.

Plenty of upside.